Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
Comparable business profile · signals at a glance
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.